Emelie Styring
1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
-
Mark
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous
(
- Contribution to journal › Article
-
Mark
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
(
- Contribution to journal › Article
- 2022
-
Mark
Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin
(
- Contribution to journal › Article
-
Mark
Intralesional margin after excision of a high-grade osteosarcoma : Is it a catastrophe?
(
- Contribution to journal › Article
- 2021
-
Mark
Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall : Better Outcome After Treatment of Late Events Compared with Early
(
- Contribution to journal › Article
- 2020
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
(
- Contribution to journal › Article
-
Mark
Soft-tissue sarcoma in adolescents and young adults compared with older adults : A report among 5000 patients from the Scandinavian Sarcoma Group Central Register
(
- Contribution to journal › Article
-
Mark
Ökad risk för fettembolisyndrom vid Duchennes muskeldystrofi
(
- Contribution to journal › Article